KRISTEN SAGER
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology MENA, AR NPI 1740423912
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology AR Exelixis Inc. All categories
General Payments — all program years on this page
$5,222.79
- Category: General Payments
- Program years: PY2018–2024
- Record count: 252
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $775.61 across 41 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $775.61 | 41 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $136.96 | 8 |
| Merck Sharp & Dohme Corporation | $76.37 | 4 |
| EISAI INC. | $50.30 | 3 |
| PFIZER INC. | $48.08 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.96 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $43.40 | 2 |
| ABBVIE INC. | $39.01 | 2 |
| Acerta Pharma LLC | $35.17 | 2 |
| Dendreon Pharmaceuticals LLC | $22.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.49 | 1 |
| Regeneron Healthcare Solutions, Inc. | $22.36 | 1 |
| SHIELD THERAPEUTICS INC | $21.59 | 1 |
| GENZYME CORPORATION | $21.27 | 1 |
| Stemline Therapeutics Inc. | $20.22 | 1 |
| AVEO Pharmaceuticals, Inc. | $20.03 | 1 |
| Myriad Genetic Laboratories, Inc. | $18.85 | 1 |
| Genentech USA, Inc. | $18.26 | 1 |
| BeiGene USA, Inc. | $17.67 | 1 |
| Deciphera Pharmaceuticals Inc. | $17.24 | 1 |
| Janssen Biotech, Inc. | $16.49 | 1 |
| Astellas Pharma US Inc | $16.40 | 1 |
| Rigel Pharmaceuticals, Inc. | $15.96 | 1 |
| Mirati Therapeutics, Inc. | $15.90 | 1 |
| GlaxoSmithKline, LLC. | $15.01 | 1 |
By program year
Records — PY2024 (41)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.